Table 2.
Clinical domain for aripiprazole prescription: | |
---|---|
1 | First episode psychosis |
2 | Acute exacerbation or relapse of psychosis |
3 | Agitation (intramuscular injection) |
4 | Long-term maintenance therapy |
5 | Onset of cardiovascular or metabolic disorders |
6 | Onset of hyperprolactinemia or sexual disorders |
7 | Occurrence of cognitive disorders |
8 | Secondary negative symptoms |
9 | Partial response (other than resistant schizophrenia) |
10 | Addictive comorbidity |
11 | Resistant schizophrenia in association with clozapine |
12 | Resistant schizophrenia as monotherapy |
13 | Resistant schizophrenia in association (without clozapine) |
14 | Pregnancy |
Themes in bold were those retained for the Delphi survey